Latest & greatest articles for amoxicillin

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on amoxicillin or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on amoxicillin and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for amoxicillin

21. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Access cutting-edge continuing education courses Find evidence to support your clinical decisions Access member-only practice content Make (...) for children's oral health Visit the Ad Council's children's oral health website Evidence Education About * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical

ADA Center for Evidence-Based Dentistry2013

22. Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures

Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures ADA Websites Access news, member benefits and ADA policy Attend ADA's premier event Take advantage of endorsed, discounted business products Access cutting-edge continuing education courses Find evidence to support your clinical (...) for children's oral health Visit the Ad Council's children's oral health website Evidence Education About * Associated Topics Indirect evidence provides poor evidence in support of concomitant use of amoxicillin/metronidazole to improve periodontal measures L. Virginia Powell DMD, GPR . Overview Systematic Review Conclusion Systematic antimicrobial therapy using a combination of amoxicillin and metronidazole as an adjunct to scaling and root planing (SRP) can enhance the clinical benefits of non-surgical

ADA Center for Evidence-Based Dentistry2013

23. Randomised controlled trial: A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment

Randomised controlled trial: A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment Article Text Therapeutics Randomised controlled trial A 10-day course of amoxicillin does not reduce symptoms of acute rhinosinusitis at day 3 of treatment Jack Anon 1

Evidence-Based Medicine (Requires free registration)2013

24. Amoxicillin for acute rhinosinusitis: a randomized controlled trial.

Amoxicillin for acute rhinosinusitis: a randomized controlled trial. 22337680 2012 02 16 2012 02 16 2016 12 15 1538-3598 307 7 2012 Feb 15 JAMA JAMA Amoxicillin for acute rhinosinusitis: a randomized controlled trial. 685-92 10.1001/jama.2012.138 Evidence to support antibiotic treatment for acute rhinosinusitis is limited, yet antibiotics are commonly used. To determine the incremental effect of amoxicillin treatment over symptomatic treatments for adults with clinically diagnosed acute (...) rhinosinusitis. A randomized, placebo-controlled trial of adults with uncomplicated, acute rhinosinusitis were recruited from 10 community practices in Missouri between November 1, 2006, and May 1, 2009. Ten-day course of either amoxicillin (1500 mg/d) or placebo administered in 3 doses per day. All patients received a 5- to 7-day supply of symptomatic treatments for pain, fever, cough, and nasal congestion to use as needed. The primary outcome was improvement in disease-specific quality of life after 3 to 4

JAMA2012 Full Text: Link to full Text with Trip Pro

25. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial.

Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. 22285055 2012 02 27 2012 03 06 2016 10 25 1474-547X 379 9817 2012 Feb 25 Lancet (London, England) Lancet Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial. 729-37 10.1016 (...) the potential to reduce the number of infants dying at home. We did a cluster-randomised controlled trial in Matiari district of rural Sindh, Pakistan. Public-sector lady health workers (LHWs) undertook community case management of WHO-defined severe pneumonia. The children in intervention clusters with suspected pneumonia were screened by LHWs and those diagnosed with severe pneumonia were prescribed oral amoxicillin syrup (90 mg/kg per day in two doses) for 5 days at home. Children in control clusters

Lancet2012

26. Randomised controlled trial: Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality

Randomised controlled trial: Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Training birth attendants in rural Zambia in neonatal resuscitation, and the use of amoxicillin coupled with facilitated referral, reduces neonatal mortality Article

Evidence-Based Medicine (Requires free registration)2011

27. Randomised controlled trial: Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media and increases risk of diarrhoea

Randomised controlled trial: Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media and increases risk of diarrhoea Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media and increases risk of diarrhoea | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Amoxicillin-clavulanate improves symptoms, reduces treatment failure in select children with acute otitis media and increases risk of diarrhoea Article Text Therapeutics Randomised

Evidence-Based Medicine (Requires free registration)2011

28. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial.

Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. 21550483 2011 05 09 2011 07 06 2016 11 25 1474-547X 377 9777 2011 May 07 Lancet (London, England) Lancet Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. 1573-9 10.1016/S0140-6736(11)60410-8 Researchers have (...) suggested that antibiotics could cure acute appendicitis. We assessed the efficacy of amoxicillin plus clavulanic acid by comparison with emergency appendicectomy for treatment of patients with uncomplicated acute appendicitis. In this open-label, non-inferiority, randomised trial, adult patients (aged 18-68 years) with uncomplicated acute appendicitis, as assessed by CT scan, were enrolled at six university hospitals in France. A computer-generated randomisation sequence was used to allocate patients

Lancet2011

29. Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial.

Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial. 22078721 2011 11 21 2011 12 07 2017 02 20 1474-547X 378 9805 2011 Nov 19 Lancet (London, England) Lancet Community case management of severe pneumonia with oral amoxicillin in children aged 2-59 months in Haripur district, Pakistan: a cluster randomised trial. 1796-803 10.1016/S0140-6736(11)61140-9 First dose oral co-trimoxazole and referral (...) are recommended for WHO-defined severe pneumonia. Difficulties with referral compliance are reported in many low-resource settings, resulting in low access to appropriate treatment. The objective in this study was to assess whether community case management by lady health workers (LHWs) with oral amoxicillin in children with severe pneumonia was equivalent to current standard of care. In Haripur district, Pakistan, 28 clusters were randomly assigned with stratification in a 1:1 ratio to intervention

Lancet2011 Full Text: Link to full Text with Trip Pro

30. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children

Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children 19564277 2009 06 30 2009 09 22 2009 12 21 1098-4275 124 1 2009 Jul Pediatrics Pediatrics Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. 9-15 10.1542/peds.2008-2902 The role of antibiotic therapy in managing acute bacterial sinusitis (ABS) in children is controversial. The purpose of this study was to determine (...) the effectiveness of high-dose amoxicillin/potassium clavulanate in the treatment of children diagnosed with ABS. This was a randomized, double-blind, placebo-controlled study. Children 1 to 10 years of age with a clinical presentation compatible with ABS were eligible for participation. Patients were stratified according to age (<6 or >or=6 years) and clinical severity and randomly assigned to receive either amoxicillin (90 mg/kg) with potassium clavulanate (6.4 mg/kg) or placebo. A symptom survey

EvidenceUpdates2009

31. Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial

Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial 18559367 2008 11 05 2008 12 31 2014 07 30 1468-3296 63 11 2008 Nov Thorax Thorax Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial. 999-1005 10.1136/thx.2008.097311 Antibiotic treatment is not recommended for acute bronchitis in immunocompetent patients in industrialised (...) countries. Whether these recommendations are relevant to the developing world and to immunocompromised patients is unknown. Randomised, triple blind, placebo controlled equivalence trial of amoxicillin compared with placebo in 660 adults presenting to two outpatient clinics in Nairobi, Kenya, with acute bronchitis but without evidence of chronic lung disease. The primary study end point was clinical cure, as defined by a >or=75% reduction in a validated Acute Bronchitis Severity Score by 14 days

EvidenceUpdates2008

32. Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media.

Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media. BACKGROUND: Acute otitis media (AOM) is a common problem in children, for which the antibiotic amoxicillin, with or without clavulanate, is frequently prescribed. OBJECTIVES: To compare the effectiveness of one or two daily doses with three or four daily doses of amoxicillin, with or without clavulanate, for the treatment of AOM in children. SEARCH STRATEGY: We searched (...) . The outcomes were assessed at the end of therapy (often 10 days) and this may have been too late to measure any differences. AUTHORS' CONCLUSIONS: This review showed insufficient evidence to judge whether once or twice daily doses of amoxicillin, with or without clavulanate, were comparable with three or four daily doses for the treatment of AOM. The evidence appears to be biased and therefore no firm conclusions can be drawn.

Cochrane2008

33. Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis

Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis The American Journal of Tropical Medicine and Hygiene | Consensus Guidelines for Dosing of Amoxicillin-Clavulanate in Melioidosis 1921 Toggle search navigation Toggle main navigation Follow us: Go Username: Password: Sign in Share Tools /recommendto/form?webId=%2Fcontent%2Fjournals%2F14761645&title=The+American+Journal+of+Tropical+Medicine+and+Hygiene&issn=0002-9637&eissn=1476-1645 The American Journal of Tropical (...) Medicine and Hygiene — Recommend this title to your library Article f Consensus Guidelines for Dosing of Amoxicillin-Clavulanate in Melioidosis Authors: 1 , 1 , 1 , 1 , 1 , 1 , 1 , 1,* View Affiliations Hide Affiliations Affiliations: 1 Reprint requests: Bart J. Currie, Menzies School of Health Research, PO Box 41096, Casuarina NT 0811. E-mail: Publisher: , Source: , , Feb 2008, p. 208 - 209 Abstract Abstract Melioidosis is an infectious disease endemic to northern Australia and Southeast Asia

Clinical Practice Guidelines Portal2008

34. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.

Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. 18177775 2008 01 07 2008 01 17 2015 06 16 1474-547X 371 9606 2008 Jan 05 Lancet (London, England) Lancet Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. 49-56 10.1016/S0140-6736(08)60071-9 WHO case management guidelines for severe pneumonia involve referral to hospital for treatment (...) with parenteral antibiotics. If equally as effective as parenteral treatment, home-based oral antibiotic treatment could reduce referral, admission, and treatment costs. Our aim was to determine whether home treatment with high-dose oral amoxicillin and inpatient treatment with parenteral ampicillin were equivalent for the treatment of severe pneumonia in children. This randomised, open-label equivalency trial was done at seven study sites in Pakistan. 2037 children aged 3-59 months with severe pneumonia were

Lancet2008

35. Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo

Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin or placebo Article Text Therapeutics Mometasone furoate nasal spray was more effective for symptom relief of acute rhinosinusitis than amoxicillin

Evidence-Based Medicine (Requires free registration)2007

36. Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials

Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials Pitsouni E (...) , Iavazzo C, Athanasiou S, Falagas M E CRD summary The authors conclude that azithromycin is as effective as erythromycin or amoxicillin for treating Chlamydia trachomatis in pregnancy and has fewer adverse effects. Although the data appear to support these conclusions, they should be interpreted with some caution given the limitations in the search and failure to adequately address inconsistencies between the primary studies. Authors' objectives To assess the effectiveness and safety of azithromycin

DARE.2007

37. Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US

Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US Cost of ciprofloxacin/dexamethasone vs amoxicillin/clavulanic acid for the treatment of acute otitis media in tympanostomy tube patients in the US Schmier J K, Waycaster C R, Wall G M Record Status (...) This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary The study compared the cost-effectiveness of ciprofloxacin-dexamethasone ear drops with oral amoxicillin-clavulanic acid for the treatment of patients with acute otitis media in the tympanostomy tube (AOMT

NHS Economic Evaluation Database.2007

38. Comparison of early intravenous to oral switch amoxicillin/clavulanate with parenteral ceftriaxone in treatment of hospitalized patients with community acquired pneumonia

Comparison of early intravenous to oral switch amoxicillin/clavulanate with parenteral ceftriaxone in treatment of hospitalized patients with community acquired pneumonia Comparison of early intravenous to oral switch amoxicillin/clavulanate with parenteral ceftriaxone in treatment of hospitalized patients with community acquired pneumonia Comparison of early intravenous to oral switch amoxicillin/clavulanate with parenteral ceftriaxone in treatment of hospitalized patients with community (...) acquired pneumonia Yaqub A, Khan Z Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined the early switch from intravenous to oral amoxicillin-clavulanate in the treatment of hospitalised patients with community-acquired

NHS Economic Evaluation Database.2005

39. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial.

Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. 15728165 2005 02 24 2005 03 01 2016 10 19 1538-3598 293 8 2005 Feb 23 JAMA JAMA Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. 949-55 The high prevalence of resistance to trimethoprim-sulfamethoxazole and other antimicrobials among Escherichia coli causing acute cystitis in women has led to increased use (...) of alternative antibiotics. One such antibiotic, amoxicillin-clavulanate, has not been well studied. To compare the efficacy of a 3-day regimen of amoxicillin-clavulanate to that of a 3-day regimen of ciprofloxacin in the treatment of acute cystitis in women. The primary study hypothesis was that the amoxicillin-clavulanate and ciprofloxacin treatment groups would differ in clinical cure. Randomized, single-blind treatment trial of 370 women, aged 18 to 45 years, with symptoms of acute uncomplicated cystitis

JAMA2005

40. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.

Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. 15451221 2004 09 28 2004 10 13 2015 06 16 1474-547X 364 9440 2004 Sep 25-Oct 1 Lancet (London, England) Lancet Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study. 1141-8 Injectable penicillin is the recommended treatment for WHO-defined severe pneumonia (lower (...) chest indrawing). If oral amoxicillin proves equally effective, it could reduce referral, admission, and treatment costs. We aimed to determine whether oral amoxicillin and parenteral penicillin were equivalent in the treatment of severe pneumonia in children aged 3-59 months. This multicentre, randomised, open-label equivalency study was undertaken at tertiary-care centres in eight developing countries in Africa, Asia, and South America. Children aged 3-59 months with severe pneumonia were admitted

Lancet2004